256
Views
5
CrossRef citations to date
0
Altmetric
REVIEW

Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis

, , ORCID Icon, , , , & ORCID Icon show all
Pages 683-693 | Received 16 Jan 2023, Accepted 24 May 2023, Published online: 05 Jun 2023

References

  • Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
  • Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67(1):328–357. doi:10.1002/hep.29367
  • Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi:10.1002/hep.28431
  • Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212–2224. doi:10.1016/S0140-6736(20)32511-3
  • Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009;50(1):204–210. doi:10.1016/j.jhep.2008.10.010
  • Miyake T, Kumagi T, Furukawa S, et al. Non-alcoholic fatty liver disease: factors associated with its presence and onset. J Gastroenterol Hepatol. 2013;28(s4):71–78. doi:10.1111/jgh.12251
  • Bai JX, Shu RM, Huang Y, Peng Z. 血尿酸与非酒精性脂肪性肝病发生风险相关性的随访队列研究 [Correlation between serum uric acid and risk of new-onset nonalcoholic fatty liver disease: a 5-year observational cohort study]. Zhonghua Gan Zang Bing Za Zhi. 2018;26(4):271–275. Chinese. doi:10.3760/cma.j.issn.1007-3418.2018.04.008
  • Cai W, Wu X, Zhang B, et al. Serum uric acid levels and nonalcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. Arq Bras Endocrinol Metabol. 2013;57(8):617–622. doi:10.1590/S0004-27302013000800006
  • Hu Y, Li Q, Min R, Deng Y, Xu Y, Gao L. The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: a cross-sectional study. PeerJ. 2021;9:e10691. doi:10.7717/peerj.10691
  • Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol. 2009;50(5):1029–1034. doi:10.1016/j.jhep.2008.11.021
  • Bao T, Ying ZY, Gong L, et al. Association between serum uric acid and nonalcoholic fatty liver disease in nonobese postmenopausal women: a cross-sectional study. Sci Rep. 2020;10(1). doi:10.1038/s41598-020-66931-9
  • Han L, Zhang Y, Yue C, Huang Y, Wu Y, Chen J. Preliminary study on risk factors for morbidity of nonalcoholic fatty liver disease in high-income male population. J Healthc Eng. 2022;2022:9331284. doi:10.1155/2022/9331284
  • Chen YL, Li H, Li S, et al. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study. BMC Gastroenterol. 2021;21(1):212. doi:10.1186/s12876-021-01782-w
  • Liu P, Ma F, Lou H, Zhu Y, Chen Y. 绝经后女性正常血尿酸水平与非酒精性脂肪性肝病的相关性 [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women]. Zhonghua Gan Zang Bing Za Zhi. 2014;22(1):53–57. Chinese. doi:10.3760/cma.j.issn.1007-3418.2014.01.012
  • Liu PJ, Ma F, Lou HP, Zhu YN, Chen Y. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. Climacteric. 2014;17(6):692–699. doi:10.3109/13697137.2014.926323
  • Fan NG, Zhang LJ, Xia ZH, Peng L, Wang YF, Peng YD. Sex-specific association between serum uric acid and nonalcoholic fatty liver disease in type 2 diabetic patients. J Diabetes Res. 2016;2016:1–6. doi:10.1155/2016/3805372
  • Wang ZL, Xu M, Hu ZG, Shrestha UK. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause. 2015;22(6):667–673. doi:10.1097/GME.0000000000000352
  • Darmawan G, Hamijoyo L, Hasan I. Association between serum uric acid and non-alcoholic fatty liver disease: a meta-analysis. Acta Med Indones. 2017;49(2):136–147.
  • Gong SL, Song JQ, Wang L, Zhang SQ, Wang YG. Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2016;28(2):132–138. doi:10.1097/MEG.0000000000000507
  • Huang F, Liu AD, Fang HS, Geng XP. Serum uric acid levels in non-alcoholic steatosis patients: a meta-analysis. Asia Pac J Clin Nutr. 2017;26(2):334–342. doi:10.6133/apjcn.092016.04
  • Liu ZT, Que SP, Zhou L, Zheng SS. Dose-response relationship of serum uric acid with metabolic syndrome and non-alcoholic fatty liver disease incidence: a meta-analysis of prospective studies. Sci Rep. 2015;5:14325.
  • Wijarnpreecha K, Panjawatanan P, Lekuthai N, Thongprayoon C, Cheungpasitporn W, Ungprasert P. Hyperuricaemia and risk of nonalcoholic fatty liver disease: a meta-analysis. Liver Int. 2017;37(6):906–918. doi:10.1111/liv.13329
  • Zhou YJ, Wei FF, Fan Y. High serum uric acid and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Biochem. 2016;49(7–8):636–642. doi:10.1016/j.clinbiochem.2015.12.010
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):1–11. doi:10.1186/s13643-021-01626-4
  • Hu J, Dong Y, Chen X, et al. Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies. Compr Psychiatry. 2015;61:78–89. doi:10.1016/j.comppsych.2015.05.001
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z
  • Cai W, Song JM, Zhang B, Sun YP, Yao H, Zhang YX. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population. TheScientificWorldJournal. 2014;2014:393628. doi:10.1155/2014/393628
  • Catanzaro R, Calabrese F, Palermo F, et al. The relationship between serum uric acid and non alcoholic fatty liver disease: a cross-sectional retrospective study. Dig Liver Dis. 2014;46:S114.
  • Chao G, Chen L. Study on the independent effect of thyroid hormone based on uric acid level on NAFLD. J Health Popul Nutr. 2021;40(1):21. doi:10.1186/s41043-021-00247-w
  • Chen Y, Huang Q, Ai P, et al. Association between serum uric acid and non-alcoholic fatty liver disease according to different menstrual status groups. Can J Gastroenterol Hepatol. 2019;2019:2763093. doi:10.1155/2019/2763093
  • Cho HC. Prevalence and factors associated with nonalcoholic fatty liver disease in a nonobese Korean population. Gut Liver. 2016;10(1):117–125. doi:10.5009/gnl14444
  • Cui L, Meng L, Wang G, et al. Prevalence and risk factors of hyperuricemia: results of the Kailuan cohort study. Mod Rheumatol. 2017;27(6):1066–1071. doi:10.1080/14397595.2017.1300117
  • Cui YL, Liu J, Shi HY, Hu WM, Song L, Zhao Q. Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population. J Diabetes Complications. 2021;35(5):107874. doi:10.1016/j.jdiacomp.2021.107874
  • Golmohammadi S, Tavasoli M, Asadi N. Prevalence and risk factors of hyperuricemia in patients with chronic kidney disease and non-alcoholic fatty liver. Clin Exp Gastroenterol. 2020;13:299–304. doi:10.2147/CEG.S253619
  • Hu MY, Liu JB, Zhou CH, Li XL. Analysis of the interaction effects among the risk factors for hyperuricaemia in adults: a cross-sectional survey in Guilin, China. Int J Clin Exp Med. 2017;10(6):9376–9386.
  • Hu XY, Li Y, Li LQ, et al. Risk factors and biomarkers of non-alcoholic fatty liver disease: an observational cross-sectional population survey. BMJ Open. 2018;8(4):e019974. doi:10.1136/bmjopen-2017-019974
  • Hwang IC, Suh SY, Suh AR, Ahn HY. The relationship between normal serum uric acid and nonalcoholic fatty liver disease. J Korean Med Sci. 2011;26(3):386–391. doi:10.3346/jkms.2011.26.3.386
  • Kuo CF, Yu KH, Luo SF, et al. Gout and risk of non-alcoholic fatty liver disease. Scand J Rheumatol. 2010;39(6):466–471. doi:10.3109/03009741003742797
  • Lee JW, Cho YK, Ryan MC, et al. Serum uric acid as a predictor for the development of nonalcoholic fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010;4(3):378–383. doi:10.5009/gnl.2010.4.3.378
  • Lee K. Relationship between uric acid and hepatic steatosis among Koreans. Diabetes Metab. 2009;35(6):447–451. doi:10.1016/j.diabet.2009.04.011
  • Lee YJ, Lee HR, Lee JH, Shin YH, Shim JY. Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults. Clin Chem Lab Med. 2010;48(2):175–180. doi:10.1515/CCLM.2010.037
  • Li Y, Song CL, Yang HH, et al. 苏州60岁及以上老年人群非酒精性肝脏脂肪变性状况及影响因素分析 [Study about the risk factors of non-alcoholic fatty liver disease among people aged over 60 years old in Suzhou]. Zhonghua yu fang yi xue za zhi. 2017;51(5):444–446. Chinese. doi:10.3760/cma.j.issn.0253-9624.2017.05.014
  • Liu C, Liu W, Zhang G, et al. Conjunctional relationship between serum uric acid and serum nickel with non-alcoholic fatty liver disease in men: a cross-sectional study. Int J Environ Res Public Health. 2022;19(11):6424.
  • Liu CQ, He CM, Chen N, et al. Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults. Sci Rep. 2016;6:38605.
  • Liu J, Xu CF, Ying LM, et al. Relationship of serum uric acid level with non-alcoholic fatty liver disease and its inflammation progression in non-obese adults. Hepatol Res. 2017;47(3):E104–E112. doi:10.1111/hepr.12734
  • Ma ZM, Zhang JB, Kang XP, et al. Hyperuricemia precedes non-alcoholic fatty liver disease with abdominal obesity moderating this unidirectional relationship: three longitudinal analyses. Atherosclerosis. 2020;311:44–51. doi:10.1016/j.atherosclerosis.2020.08.006
  • Pan XT, Xie XX, Peng HW, et al. Risk prediction for non-alcoholic fatty liver disease based on biochemical and dietary variables in a Chinese Han Population. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.00220
  • Ryu S, Chang Y, Kim SG, Cho J, Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism. 2011;60(6):860–866. doi:10.1016/j.metabol.2010.08.005
  • Shen Y, Wang Y, Chang C, Li S, Li W, Ni B. Prevalence and risk factors associated with hyperuricemia among working population at high altitudes: a cross-sectional study in Western China. Clin Rheumatol. 2019;38(5):1375–1384. doi:10.1007/s10067-018-4391-9
  • Shih MH, Lazo M, Liu SH, Bonekamp S, Hernaez R, Clark JM. Association between serum uric acid and nonalcoholic fatty liver disease in the US population. J Formos Med Assoc. 2015;114(4):314–320. doi:10.1016/j.jfma.2012.11.014
  • Sirota JC, McFann K, Targher G, Johnson RJ, Chonchol M, Jalal DI. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: liver ultrasound data from the national health and nutrition examination survey. Metabolism. 2013;62(3):392–399. doi:10.1016/j.metabol.2012.08.013
  • Tang Y, Xu Y, Liu P, et al. No evidence for a causal link between serum uric acid and nonalcoholic fatty liver disease from the dongfeng-tongji cohort study. Oxid Med Cell Longev. 2022;2022:6687626. doi:10.1155/2022/6687626
  • Tung TH, Chang TH, Chiu WH, et al. Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: experience at a teaching hospital. BMC Res Notes. 2011;4:315. doi:10.1186/1756-0500-4-315
  • Wang M, Wang M, Zhang R, et al. A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study. PeerJ. 2022;10:e13022. doi:10.7717/peerj.13022
  • Wang Z, Xu M, Peng J, et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Exp Gerontol. 2013;48(8):705–709. doi:10.1016/j.exger.2013.05.059
  • Wei F, Li J, Chen C, et al. Higher serum uric acid level predicts non-alcoholic fatty liver disease: a 4-year prospective cohort study. Front Endocrinol. 2020;11:179. doi:10.3389/fendo.2020.00179
  • Wu SJ, Zhu GQ, Ye BZ, et al. Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study. Medicine. 2015;94(17):e802. doi:10.1097/MD.0000000000000802
  • Xie Y, Wang M, Zhang Y, et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PLoS One. 2013;8(7):e67152. doi:10.1371/journal.pone.0067152
  • Xu C, Yu C, Xu L, Miao M, Li Y, Ng IOL. High serum uric acid increases the risk for nonalcoholic fatty liver disease: a prospective observational study. PLoS One. 2010;5(7):e11578. doi:10.1371/journal.pone.0011578
  • Yamada T, Suzuki S, Fukatsu M, Wada T, Yoshida T, Joh T. Elevated serum uric acid is an independent risk factor for nonalcoholic fatty liver disease in Japanese undergoing a health checkup. Acta Gastroenterol Belg. 2010;73(1):12–17.
  • Yang C, He Q, Chen Z, et al. A bidirectional relationship between hyperuricemia and metabolic dysfunction-associated fatty liver disease. Front Endocrinol. 2022;13:821689. doi:10.3389/fendo.2022.821689
  • Yang C, Yang SJ, Xu WW, Zhang JH, Fu WG, Feng CH. Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: a retrospective cohort study. PLoS One. 2017;12(5):e0177249.
  • Yang HH, Li DM, Song XC, et al. Joint associations of serum uric acid and ALT with NAFLD in elderly men and women: a Chinese cross-sectional study. J Transl Med. 2018;16. doi:10.1186/s12967-018-1657-6
  • Yu HF, Zhao L, Liu LJ, Li YF, Sun J, Liu YD. Relationship between serum uric acid level and nonalcoholic fatty liver disease in type 2 diabetes patients. Medicine. 2021;100(33):e26946. doi:10.1097/MD.0000000000026946
  • Yu XL, Shu L, Shen XM, Zheng XY, Zheng PF. Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese an observational study. Medicine. 2017;96(39):e8164. doi:10.1097/MD.0000000000008164
  • Zhang S, Du T, Li M, Lu H, Lin X, Yu X. Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia. Medicine. 2017;96(12):e6381. doi:10.1097/MD.0000000000006381
  • Zheng XY, Gong LL, Luo R, et al. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults. Lipids Health Dis. 2017;16(1). doi:10.1186/s12944-017-0531-5
  • Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25(2):210–216. doi:10.1097/BOR.0b013e32835d951e
  • Zhu Y, Hu Y, Huang T, et al. High uric acid directly inhibits insulin signalling and induces insulin resistance. Biochem Biophys Res Commun. 2014;447(4):707–714. doi:10.1016/j.bbrc.2014.04.080
  • Vacca M, Allison M, Griffin JL, Vidal-Puig A. Fatty acid and glucose sensors in hepatic lipid metabolism: implications in NAFLD. Semin Liver Dis. 2015;35(3):250–261. doi:10.1055/s-0035-1562945
  • Xu C. Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back. Hepatol Int. 2016;10(2):286–293. doi:10.1007/s12072-015-9682-5
  • Wan X, Xu C, Lin Y, et al. Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism. J Hepatol. 2016;64(4):925–932. doi:10.1016/j.jhep.2015.11.022
  • Xu C, Wan X, Xu L, et al. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: one stone hits two birds. J Hepatol. 2015;62(6):1412–1419. doi:10.1016/j.jhep.2015.01.019